Risk Management Shapes FDA Policies and Practices

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-08-02-2002, Volume 26, Issue 8

In response to increasing concern about drug safety, FDA has implemented several administrative and policy changes, inclduing the new Office of Pharmacoepidemiology and Statistical Science and a renewed focus on risk assessment.

Related Content:

Quality SystemsRegulatory WatchPharmaceutical Technology-08-02-2002
Susan Schniepp of Regulatory Compliance Associates Explores the Impact of QMS on Quality Maturity (INTERPHEX 2024)
Keynote Session Highlights Importance of Process Validation and Data Integrity (INTERPHEX 2024)
FDA Establishes Center for Clinical Trial Innovation